Free Trial

TherapeuticsMD (TXMD) Stock Price, News & Analysis

TherapeuticsMD logo
$1.18 -0.02 (-1.67%)
Closing price 07/11/2025 03:53 PM Eastern
Extended Trading
$1.20 +0.02 (+1.69%)
As of 07/11/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About TherapeuticsMD Stock (NASDAQ:TXMD)

Key Stats

Today's Range
$1.16
$1.23
50-Day Range
$1.08
$1.52
52-Week Range
$0.70
$2.44
Volume
12,413 shs
Average Volume
160,801 shs
Market Capitalization
$13.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

TherapeuticsMD Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
17th Percentile Overall Score

TXMD MarketRank™: 

TherapeuticsMD scored higher than 17% of companies evaluated by MarketBeat, and ranked 859th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for TherapeuticsMD.

  • Percentage of Shares Shorted

    14.02% of the float of TherapeuticsMD has been sold short.
  • Short Interest Ratio / Days to Cover

    TherapeuticsMD has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in TherapeuticsMD has recently increased by 35,500.96%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    TherapeuticsMD does not currently pay a dividend.

  • Dividend Growth

    TherapeuticsMD does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    14.02% of the float of TherapeuticsMD has been sold short.
  • Short Interest Ratio / Days to Cover

    TherapeuticsMD has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in TherapeuticsMD has recently increased by 35,500.96%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    TherapeuticsMD has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.00 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for TherapeuticsMD this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, TherapeuticsMD insiders have bought more of their company's stock than they have sold. Specifically, they have bought $815.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 2.30% of the stock of TherapeuticsMD is held by insiders.

  • Percentage Held by Institutions

    Only 30.74% of the stock of TherapeuticsMD is held by institutions.

  • Read more about TherapeuticsMD's insider trading history.
Receive TXMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TherapeuticsMD and its competitors with MarketBeat's FREE daily newsletter.

TXMD Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
See More Headlines

TXMD Stock Analysis - Frequently Asked Questions

TherapeuticsMD's stock was trading at $0.86 on January 1st, 2025. Since then, TXMD shares have increased by 37.2% and is now trading at $1.18.

TherapeuticsMD, Inc. (NASDAQ:TXMD) released its quarterly earnings data on Tuesday, May, 13th. The company reported ($0.06) earnings per share (EPS) for the quarter. The firm earned $0.39 million during the quarter. TherapeuticsMD had a negative trailing twelve-month return on equity of 7.86% and a negative net margin of 114.07%.

TherapeuticsMD's stock reverse split on Monday, May 9th 2022.The 1-50 reverse split was announced on Monday, May 9th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 9th 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Shares of TXMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that TherapeuticsMD investors own include Voyager Therapeutics (VYGR), Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Marinus Pharmaceuticals (MRNS), AU Optronics (AUOTY) and The RMR Group (RMR).

Company Calendar

Last Earnings
5/13/2025
Today
7/12/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TXMD
Previous Symbol
NYSEMKT:TXMD
CIK
25743
Employees
420
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.18 million
Net Margins
-114.07%
Pretax Margin
-119.61%
Return on Equity
-7.86%
Return on Assets
-5.46%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.64
Quick Ratio
2.64

Sales & Book Value

Annual Sales
$1.76 million
Price / Sales
7.76
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.37 per share
Price / Book
0.50

Miscellaneous

Outstanding Shares
11,570,000
Free Float
11,308,000
Market Cap
$13.65 million
Optionable
Optionable
Beta
0.59

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:TXMD) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners